Status:
COMPLETED
Genicular Nerve Block in Rheuamtoid Arthritis
Lead Sponsor:
Sohag University
Conditions:
Pain
Joint Function Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
N=64 RA patients either early or established disease diagnosed after ACR/EULAR criteria 2010 with unilateral persistent knee arthritis. They were randomly assigned into two groups; group 1 received ge...
Eligibility Criteria
Inclusion
- RA patients
- Age \> 18
- unilateral persistent knee arthritis
Exclusion
- Participants with severe knee osteoarthritis
- peripheral neuropathy
- psoriatic arthritis
- skin infection
- or those who have allergy for Bupivacaine
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2020
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04361513
Start Date
April 15 2020
End Date
July 28 2020
Last Update
June 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia university
Minya, Egypt, 82749